IQANOVA product sheets · October 2026

MIDD Foundation Package

Models you can audit and trust.

One versioned ZIP: executable model, data, reports, manuscripts, patent screens, due diligence and regulatory drafts, each file labelled by evidence status.

The exact contents are defined by the agreed brief. Optional and separately commissioned outputs are not automatically included.

7-page product sheet  ·  October 2026  ·  Pricing to be discussed

Product enquiries: sales@iqanova.org

What's in the package

Auditable deliverables, organised for review

From model files and provenance records to versioned simulations, checked analyses and scope-specific reports.

19organised ZIP folders
22Critic checks before claims
358catalogued possible outputs; order selects applicable items
D0–D10lifecycle stages for diligence and regulatory review
01

Model, data & replay

Native model and SBML branches, equations, pinned simulation environments, replay logs and properly labelled real, semi-synthetic or synthetic data.

02

Verification & evidence

Provenance, source and rights registers, rate-law and unit checks, validation records, uncertainty analysis and evidence-aware claim warnings.

03

Decision & regulatory support

Stage diligence records, risk registers, regulatory gap matrices and draft documents. Full due diligence reports and extension modules are separately commissioned.

Coverage

Model families and scales

Work can be scoped from intracellular and cellular models to tissue, organ, whole-body and whole-organism modelling.

PK/PDPopulation PK/PDPBPK/PBBMQSPQSTNetworkAgent-basedSpatial/PDEDisease progressionAI/ML hybrid

Scaffold: The EHMN2027 intracellular and cellular model family is supplied separately, as stated in the product sheet.

The complete product sheet

Explore the 7-page flyer

The PDF details the folder structure, output library, manuscripts, patent and rights screening, decision-grade due diligence, lifecycle dossier and how to commission a model.

  1. Foundation Package overview
  2. What's inside the ZIP
  3. 358-output catalogue across nine families
  4. Manuscripts and patent intelligence
  5. Decision-grade due diligence
  6. Regulatory lifecycle dossier (D0–D10)
  7. Ordering and maintenance options
Start with your brief

Order a model tailored to your question

Define area, targets, drugs, endpoints, model family, evidence and licence. IQANOVA returns a scoped quote.